178 related articles for article (PubMed ID: 28107702)
1. C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.
Yue D; Wang Y; Sun Y; Niu Y; Chang C
Neoplasia; 2017 Feb; 19(2):135-144. PubMed ID: 28107702
[TBL] [Abstract][Full Text] [Related]
2. C1QBP negatively regulates the activation of oncoprotein YBX1 in the renal cell carcinoma as revealed by interactomics analysis.
Wang Y; Yue D; Xiao M; Qi C; Chen Y; Sun D; Zhang N; Chen R
J Proteome Res; 2015 Feb; 14(2):804-13. PubMed ID: 25497084
[TBL] [Abstract][Full Text] [Related]
3. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor (AR) suppresses miRNA-145 to promote renal cell carcinoma (RCC) progression independent of VHL status.
Chen Y; Sun Y; Rao Q; Xu H; Li L; Chang C
Oncotarget; 2015 Oct; 6(31):31203-15. PubMed ID: 26304926
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor (AR) promotes clear cell renal cell carcinoma (ccRCC) migration and invasion via altering the circHIAT1/miR-195-5p/29a-3p/29c-3p/CDC42 signals.
Wang K; Sun Y; Tao W; Fei X; Chang C
Cancer Lett; 2017 May; 394():1-12. PubMed ID: 28089832
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor decreases renal cell carcinoma bone metastases via suppressing the osteolytic formation through altering a novel circEXOC7 regulatory axis.
Gong D; Sun Y; Guo C; Sheu TJ; Zhai W; Zheng J; Chang C
Clin Transl Med; 2021 Mar; 11(3):e353. PubMed ID: 33783995
[TBL] [Abstract][Full Text] [Related]
7. C1QBP suppresses cell adhesion and metastasis of renal carcinoma cells.
Wang Y; Fu D; Su J; Chen Y; Qi C; Sun Y; Niu Y; Zhang N; Yue D
Sci Rep; 2017 Apr; 7(1):999. PubMed ID: 28428626
[TBL] [Abstract][Full Text] [Related]
8. The m
Gong D; Zhang J; Chen Y; Xu Y; Ma J; Hu G; Huang Y; Zheng J; Zhai W; Xue W
J Exp Clin Cancer Res; 2019 Jun; 38(1):233. PubMed ID: 31159832
[TBL] [Abstract][Full Text] [Related]
9. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling.
Guan Z; Li C; Fan J; He D; Li L
Sci Rep; 2016 Nov; 6():37085. PubMed ID: 27848972
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth.
Wang K; Sun Y; Guo C; Liu T; Fei X; Chang C
Cell Death Dis; 2019 Apr; 10(5):339. PubMed ID: 31000693
[TBL] [Abstract][Full Text] [Related]
13. CD4 + T cells promote renal cell carcinoma proliferation via modulating YBX1.
Wang Y; Wang Y; Xu L; Lu X; Fu D; Su J; Geng H; Qin G; Chen R; Quan C; Niu Y; Yue D
Exp Cell Res; 2018 Feb; 363(1):95-101. PubMed ID: 29289594
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia increases RCC stem cell phenotype via altering the androgen receptor (AR)-lncTCFL5-2-YBX1-SOX2 signaling axis.
Guo C; Sun Y; Zhai W; Yao X; Gong D; You B; Huang CP; Zheng J; Chang C
Cell Biosci; 2022 Nov; 12(1):185. PubMed ID: 36397101
[TBL] [Abstract][Full Text] [Related]
15. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.
Song W; Li L; He D; Xie H; Chen J; Yeh CR; Chang LS; Yeh S; Chang C
Cancer Lett; 2015 Nov; 368(1):71-78. PubMed ID: 26231735
[TBL] [Abstract][Full Text] [Related]
16. Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11→miRNA-541→androgen receptor (AR)→MMP9 signaling.
Hu S; Li L; Yeh S; Cui Y; Li X; Chang HC; Jin J; Chang C
Mol Oncol; 2015 Jan; 9(1):44-57. PubMed ID: 25135278
[TBL] [Abstract][Full Text] [Related]
17. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.
Wang Y; Ou Z; Sun Y; Yeh S; Wang X; Long J; Chang C
Oncogene; 2017 Mar; 36(12):1644-1654. PubMed ID: 27869170
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
20. Dihydrotestosterone promotes kidney cancer cell proliferation by activating the STAT5 pathway via androgen and glucocorticoid receptors.
Pak S; Kim W; Kim Y; Song C; Ahn H
J Cancer Res Clin Oncol; 2019 Sep; 145(9):2293-2301. PubMed ID: 31401673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
